Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

8PF5

Crystal structure of Trypanosoma brucei trypanothione reductase in complex with 1-(3,4-dichlorobenzyl)-4-(((5-((4-fluorophenethyl)carbamoyl)furan-2-yl)methyl)carbamoyl)-1-(3-phenylpropyl)piperazin-1-ium

Summary for 8PF5
Entry DOI10.2210/pdb8pf5/pdb
Related8PF3 8PF4
DescriptorTrypanothione reductase, FLAVIN-ADENINE DINUCLEOTIDE, 4-[(3,4-dichlorophenyl)methyl]-~{N}-[[5-[2-(4-fluorophenyl)ethylcarbamoyl]furan-2-yl]methyl]-4-(3-phenylpropyl)-1,4$l^{4}-diazinane-1-carboxamide, ... (8 entities in total)
Functional Keywordsoxidoreductase activity, nucleotide binding, flavoenzyme, inhibitor binding, oxidoreductase
Biological sourceTrypanosoma brucei
More
Total number of polymer chains4
Total formula weight220269.17
Authors
Exertier, C.,Antonelli, L.,Fiorillo, A.,Ilari, A. (deposition date: 2023-06-15, release date: 2024-04-03, Last modification date: 2024-11-06)
Primary citationExertier, C.,Salerno, A.,Antonelli, L.,Fiorillo, A.,Ocello, R.,Seghetti, F.,Caciolla, J.,Uliassi, E.,Masetti, M.,Fiorentino, E.,Orsini, S.,Di Muccio, T.,Ilari, A.,Bolognesi, M.L.
Fragment Merging, Growing, and Linking Identify New Trypanothione Reductase Inhibitors for Leishmaniasis.
J.Med.Chem., 67:402-419, 2024
Cited by
PubMed Abstract: Trypanothione reductase (TR) is a suitable target for drug discovery approaches against leishmaniasis, although the identification of potent inhibitors is still challenging. Herein, we harnessed a fragment-based drug discovery (FBDD) strategy to develop new TR inhibitors. Previous crystallographic screening identified fragments -, which provided ideal starting points for a medicinal chemistry campaign. investigations revealed critical hotspots in the TR binding site, guiding our structure- and ligand-based structure-actvity relationship (SAR) exploration that yielded fragment-derived compounds -. A trend of improvement in TR inhibition was detected along the optimization and confirmed by the crystal structures of , , and in complex with TR. Compound showed the best TR inhibitory profile ( = 0.2 μM), whereas was the best one in terms of and activity. Although further fine-tuning is needed to improve selectivity, we demonstrated the potentiality of FBDD on a classic but difficult target for leishmaniasis.
PubMed: 38164929
DOI: 10.1021/acs.jmedchem.3c01439
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.42 Å)
Structure validation

227344

건을2024-11-13부터공개중

PDB statisticsPDBj update infoContact PDBjnumon